Market Overview:
The Global Veno-Artrial ECMO System Market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of respiratory and cardiac diseases, growing awareness about ECMO therapy, and technological advancements in ECMO systems. Based on type, the market is segmented into desktop ECMO and mobile ECMO. Desktop ECMO systems are used for patients who are not critically ill and can be treated in a hospital setting. Mobile ECMO systems are used for patients who are critically ill and require treatment outside of a hospital setting. The mobileEC MO segment is expected to grow at a higher CAGR than the desktopEC MO segment during the forecast period from 2018 to 2030 owingto its advantages such as easy transportation, less time required for set up,and lower cost of ownership as compared to desktopEC MO systems. Based on application,the market is divided into neonatal (newborns), pediatric (children), adult (adults),and other applications(such as cardiogenic shock).
Product Definition:
The Veno-Artrial ECMO System is a device that helps to pump blood from the body and oxygenate it outside of the body. This system is often used in patients who are suffering from heart failure or other cardiac issues. The importance of this system is that it can help to improve the patient's prognosis and may even be able to help save their life.
Desktop ECMO:
A desktop ECMO system is a device that helps in the delivery of respiratory support when cardiopulmonary bypass is not possible. It works by providing oxygen from a portable source to the patient’s lungs, thus enabling blood flow through alternate routes.
The global desktop ECMO market was valued at USD 648 million in 2016 and it is expected to grow at a CAGR of XX% during the forecast period.
Mobile ECMO:
Mobile ECMO (MECO) is a technique of providing veno-arterial support to patients suffering from cardiopulmonary failure. It provides the patient with a means to be treated at home and improves the quality of life. The treatment includes insertion of catheters in veins for obtaining arterial blood, which is then pumped by machines to organs or tissues via the heart.
Application Insights:
The adult segment held the largest share of over 70.0% in 2017. The high prevalence of chronic conditions, such as heart diseases and cancer, results in higher number of ECMO procedures being performed for patients above 18 years. In addition, a rise in the adoption of smart devices that aid with remote monitoring is expected to drive the growth among adults as well as pediatric population undergoing ECMO therapy.
The neonatal segment is anticipated to witness significant growth owing to increasing incidence rates for preterm birth and infant mortality across various regions including North America and Europe-Asia Pacific rim countries along with Middle East & Africa countries such as Saudi Arabia, UAE etc., High costs associated with medical care coupled with limited treatment options are driving factors for growing incidences related to preterm birth and infant mortality across developed nations globally which eventually leads towards an increase in demand for veno-arterial extracorporeal membrane oxygenation (ECMO) systems especially during neonatal period.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness about venous disorders are some of the major factors responsible for this dominance. In addition, growing preference for technologically advanced medical devices is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rapidly improving healthcare infrastructure and rising patient awareness levels regarding advanced treatment options offered by veno-arterial ECMO systems. Moreover, a large number of patients suffering from chronic kidney disease are present in this region which can be treated with these systems effectively; hence driving demand during the forecast period.
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing rapidly. This is mainly due to the changing lifestyle and environmental factors. Respiratory diseases are one of the leading causes of death worldwide. Veno-artrial ECMO system helps in treating these respiratory diseases and thus, its demand is expected to increase in the coming years.
- Technological advancements: The technology for veno-artrial ECMO systems is constantly evolving with new innovations being made in order to make these systems more efficient and user-friendly. This has resulted in an increase in their adoption rate across hospitals and clinics worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veno-Artrial ECMO System Market Research Report
By Type
Desktop ECMO, Mobile ECMO
By Application
Neonatal, Pediatric, Adult
By Companies
Medtronic, Maquet Holding, Sorin Group, Xenios AG, ALung Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Veno-Artrial ECMO System Market Report Segments:
The global Veno-Artrial ECMO System market is segmented on the basis of:
Types
Desktop ECMO, Mobile ECMO
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neonatal, Pediatric, Adult
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Maquet Holding
- Sorin Group
- Xenios AG
- ALung Technologies
Highlights of The Veno-Artrial ECMO System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Desktop ECMO
- Mobile ECMO
- By Application:
- Neonatal
- Pediatric
- Adult
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veno-Artrial ECMO System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veno-Artrial ECMO is a system that helps to provide oxygen and other nutrients to the heart and lungs while the patient is in a medically induced coma.
Some of the major players in the veno-artrial ecmo system market are Medtronic, Maquet Holding, Sorin Group, Xenios AG, ALung Technologies.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veno-Artrial ECMO System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veno-Artrial ECMO System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veno-Artrial ECMO System Market - Supply Chain
4.5. Global Veno-Artrial ECMO System Market Forecast
4.5.1. Veno-Artrial ECMO System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veno-Artrial ECMO System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Veno-Artrial ECMO System Market Absolute $ Opportunity
5. Global Veno-Artrial ECMO System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Veno-Artrial ECMO System Market Size and Volume Forecast by Type
5.3.1. Desktop ECMO
5.3.2. Mobile ECMO
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Veno-Artrial ECMO System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Veno-Artrial ECMO System Market Size and Volume Forecast by Application
6.3.1. Neonatal
6.3.2. Pediatric
6.3.3. Adult
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Veno-Artrial ECMO System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Veno-Artrial ECMO System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Veno-Artrial ECMO System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Veno-Artrial ECMO System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Veno-Artrial ECMO System Demand Share Forecast, 2019-2026
9. North America Veno-Artrial ECMO System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Veno-Artrial ECMO System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Veno-Artrial ECMO System Market Size and Volume Forecast by Application
9.4.1. Neonatal
9.4.2. Pediatric
9.4.3. Adult
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Veno-Artrial ECMO System Market Size and Volume Forecast by Type
9.7.1. Desktop ECMO
9.7.2. Mobile ECMO
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Veno-Artrial ECMO System Demand Share Forecast, 2019-2026
10. Latin America Veno-Artrial ECMO System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Veno-Artrial ECMO System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Veno-Artrial ECMO System Market Size and Volume Forecast by Application
10.4.1. Neonatal
10.4.2. Pediatric
10.4.3. Adult
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Veno-Artrial ECMO System Market Size and Volume Forecast by Type
10.7.1. Desktop ECMO
10.7.2. Mobile ECMO
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Veno-Artrial ECMO System Demand Share Forecast, 2019-2026
11. Europe Veno-Artrial ECMO System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Veno-Artrial ECMO System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Veno-Artrial ECMO System Market Size and Volume Forecast by Application
11.4.1. Neonatal
11.4.2. Pediatric
11.4.3. Adult
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Veno-Artrial ECMO System Market Size and Volume Forecast by Type
11.7.1. Desktop ECMO
11.7.2. Mobile ECMO
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectins by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Veno-Artrial ECMO System Demand Share, 2019-2026
12. Asia Pacific Veno-Artrial ECMO System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Veno-Artrial ECMO System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Veno-Artrial ECMO System Market Size and Volume Forecast by Application
12.4.1. Neonatal
12.4.2. Pediatric
12.4.3. Adult
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Veno-Artrial ECMO System Market Size and Volume Forecast by Type
12.7.1. Desktop ECMO
12.7.2. Mobile ECMO
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Veno-Artrial ECMO System Demand Share, 2019-2026
13. Middle East & Africa Veno-Artrial ECMO System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Veno-Artrial ECMO System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Veno-Artrial ECMO System Market Size and Volume Forecast by Application
13.4.1. Neonatal
13.4.2. Pediatric
13.4.3. Adult
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Veno-Artrial ECMO System Market Size and Volume Forecast by Type
13.7.1. Desktop ECMO
13.7.2. Mobile ECMO
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Veno-Artrial ECMO System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Veno-Artrial ECMO System Market: Market Share Analysis
14.2. Veno-Artrial ECMO System Distributors and Customers
14.3. Veno-Artrial ECMO System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Maquet Holding
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sorin Group
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Xenios AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ALung Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
